European Union's Medical Body Backs 2 New Covid Treatments
NDTV
GlaxoSmithKline's Xevudy drug and Kineret, an immunosuppressive used to treat inflammatory conditions from Swedish firm Orphan Biovitrum, have been recommended by the agency.
European Union regulators on Thursday recommended two new treatments against Covid-19 for use in the bloc.
The European Medicines Agency (EMA) said Kineret, an immunosuppressive produced by Swedish Orphan Biovitrum to treat inflammatory conditions, could "decrease lower airway damage, preventing development of severe respiratory failure".
It said also that GlaxoSmithKline's Xevudy drug had shown in a study that it "significantly reduces hospitalisation and deaths in patients with at least one underlying condition".
Kineret is already recommended by the EMA to treat various conditions, with the agency expanding its listing to cover Covid-19.
